Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: A high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure

Carcinogenesis

Volumn 20, Issue 7, 1999, Pages 1253-1259

  Koivisto, Pertti ^a   Kilpeläinen, Ilkka ^b   Rasanen, Ilpo ^c   Adler, Ilse Dore ^d   Pacchierotti, Francesca ^e   Peltonen, Kimmo ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e ENEA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE; DEOXYGUANOSINE; DEOXYGUANOSINE DERIVATIVE; DEOXYGUANOSINE PHOSPHATE; DNA; GUANINE; GUANINE DERIVATIVE; N7 (2,3,4 TRIHYDROXYBUTAN 1 YL)GUANINE; PHOSPHORUS 32; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; ISOTOPE LABELING; LUNG CARCINOGENESIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BUTADIENES; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; GLYCOLS; GUANINE; HUMANS; INHALATION EXPOSURE; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PHOSPHORUS RADIOISOTOPES;

EID: 0344349003     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.7.1253     Document Type: Article

References (43)

1. IARC (1992) 1,3-butadiene. IARC Monogr. Eval. Carcinog. Risks Hum., 54, 237-285.
2. Malvoisin, E., Lhoest, G., Poncelet, F., Roberfroid, M. and Mercier, M. (1979) Identification and guantitation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene. J. Chromatogr., 178, 419-425.
3. Malvoisin, E. and Roberfroid, M. (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica, 12, 137-144.
4. Duescher, R.J. and Elfarra, A.A. (1994) Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys., 311, 342-349.
5. Krause, R.J. and Elfarra, A.A. (1997) Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch. Biochem. Biophys., 337, 176-184.
6. Cheng, X. and Ruth, J.A. (1993) A simplified methodology for quantitation of butadiene metabolites. Application to the study of 1,3-butadiene metabolism by rat liver microsomes. Drug. Metab. Dispos., 21, 121-124.
7. Himmelstein, M.W., Asgharian, B. and Bond, J.A. (1995) High concentrations of butadiene epoxides in livers and lungs of mice compared with rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol., 132, 281-288.
8. Thornton-Manning, J.R., Dahl, A.R., Bechtold, W.E., Griffith, W.C. Jr and Henderson, R.F. (1995) Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis, 16, 1723-1731.
9. Carpenter, C.P., Shaffer, C.B., Weil, C.S. and Smyth, H.F. (1944) Studies on the inhalation of 1,3-butadiene; with a comparison of its narcotic effect with benzol, toluol and styrene and a note on the elimination of styrene by the human. J. Ind. Hyg. Toxicol., 26, 69-78.
10. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis, 15, 713-717.
11. Cochrane, J.E. and Skopek, T.R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis, 15, 719-723.
12. Adler, I.D., Kliesch, U., Nylund, L. and Peltonen, K. (1997) In vitro and in vivo mutagenicity of the butadiene metabolites butadiene diolepoxide, butadiene monoepoxide and diepoxybutane. Mutagenesis, 12, 339-345.
13. Melnick, R.L. and Huff J. (1992) 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans. Rev. Environ. Contam. Toxicol., 124, 111-144.
14. Nieusma, J.L., Claffey, D.J., Maniglier-Poulet, C., Imiolczyk, T., Ross, D. and Ruth, J.A. (1997) Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes. Chem. Res. Toxicol., 10, 450-456.
15. Delzell, E., Sathiakumar, N., Hovinga, M., Macaluso, M., Julian, J., Larson, R., Cole, P. and Muir, D.C. (1996) A follow-up study of synthetic rubber workers. Toxicology, 113, 182-189.
16. Macaluso, M., Larson, R., Delzell, E., Sathiakumar, N., Hovinga, M., Julian, J., Muir, D. and Cole, P. (1996) Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology, 113, 190-202.
17. Citti, L., Gervasi, P.G., Turchi, G., Bellucci, G. and Bianchini, R. (1984) The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts. Carcinogenesis, 5, 47-52.
18. 32P-post-labelling/HPLC assay reveals an enantioselective adduct formation in N7 guanine residues in vivo after 1,3-butadiene inhalation exposure. Carcinogenesis, 18, 439-443.
19. Tretyakova, N., Lin, Y., Sangaiah, R., Upton, P.B. and Swenberg, J.A. (1997) Identification and quantitation of DNA adducts from calf thymus DNA exposed to 3,4-epoxy-1-butene. Carcinogenesis, 18, 137-147.
20. 6-adenine adducts. Carcinogenesis, 16, 2999-3007.
21. 32P-post-labeling and HPLC. Environ. Health Perspect., 104, 655-657.
22. Tretyakova, N., Sangaiah, R., Yen, T.Y. and Swenberg, J.A. (1997) Synthesis, characterization and in vitro quantitation of N-7-guanine adducts of diepoxybutane. Chem. Res. Toxicol., 10, 779-785.
23. Lawley, P.D. and Brookes, P. (1967) Interstrand cross-linking of DNA by difunctional alkylating agents. J. Mol. Biol., 25, 143-160.
24. Millard, J.T. and White, M.M. (1993) Diepoxybutane cross-links DNA at 5′-GNC sequences. Biochemistry, 32, 2120-2124.
25. Ristau, C., Deutschmann, S., Laib, R.J. and Ottenwalder, H. (1990) Detection of diepoxybutane-induced DNA-DNA crosslinks by cesium trifluoracetate (CsTFA) density-gradient centrifugation. Arch. Toxicol., 64, 343-344.
26. 32P-post-labelling. Carcinogenesis, 15, 1903-1910.
27. 32P-post-labeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry. Mutat. Res., 371, 87-104.
28. 6-adenine adducts of epoxybutanediol in vivo after 1,3-butadiene exposure. Toxicol. Lett., 102-103, 591-594.
29. Kreiling, R., Laib, R.J. and Bolt, H.M. (1986) Alkylation of nuclear proteins and DNA after exposure of rats and mice to [1,4-14C] 1,3-butadiene. Toxicol. Lett., 30, 131-136.
30. Jelitto, B., Vangala, R.R. and Laib, R.J. (1989) Species differences in DNA damage by butadiene: role of diepoxybutane. Arch. Toxicol. Suppl., 13, 246-249.
31. Lahdetie, J., Peltonen, K. and Sjoblom, T. (1997) Germ cell mutagenicity of three metabolites of 1,3-butadiene in the rat: induction of spermatid micronuclei by butadiene mono-, di- and diolepoxides in vivo. Environ. Mol. Mutagen., 29, 230-239.
32. 32P-post-labelling technique to detect DNA-adducts by cisplatin and methylating agents. Prog. Clin. Biol. Res., 340C, 293-300.
33. 32P-post-labelling of 2-hydroxyethylated, ethylated and methylated adducts of 2′-deoxyguanosine 3′-monophosphate. Carcinogenesis, 11, 1389-1392.
34. Kumar, R. and Hemminki, K. (1996) Separation of 7-methyl- and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC. Carcinogenesis, 17, 485-492.
35. Koivisto, P., Adler, I.D., Pacchierotti, F. and Peltonen, K. (1998) DNA adducts in mouse testis and lung after inhalation exposure to 1,3-butadiene. Mutat. Res., 397, 3-10.
36. Hall, R.H. (1971) The Modified Nucleosides in Nucleic Acids. Columbia University Press, New York and London.
37. Lawley, P.D., Orr, D.J. and Jarman, M. (1975) Isolation and identification of products from alkylation of nucleic acids: ethyl- and isopropyl-purines. Biochem. J., 145, 73-84.
38. Sugiura, K. and Goto, M. (1981) Mutagenicities of styrene oxide derivatives on bacterial test systems: relationship between mutagenic potencies and chemical reactivity. Chem. Biol. Interact., 35, 71-91.
39. Latif, F., Moschel, R.C., Hemminki, K. and Dipple, A. (1988) Styrene oxide as a stereochemical probe for the mechanism of aralkylation at different sites on guanosine. Chem. Res. Toxicol., 1, 364-369.
40. Neagu, I., Koivisto, P., Neagu, C., Kostiainen, R., Stenby, K. and Peltonen, K. (1995) Butadiene monoxide and deoxyguanosine alkylation products at the N7-position. Carcinogenesis, 16, 1809-1813.
41. Ehrenberg, L. and Hussain, S. (1981) Genetic toxicity of some important epoxides. Mutat. Res., 86, 1-113.
42. Nieusma, J.L., Claffey, D.J., Ruth, J.A. and Ross, D. (1998) Stereochemical aspects of the conjugation of epoxide metabolites of butadiene with glutathione in rat liver cytosol and freshly isolated rat hepatocytes. Toxicol. Sci., 43, 102-109.
43. Perez, H.L., Lahdetie, J., Landin, H., Kilpelainen, I., Koivisto, P., Peltonen, K. and Osterman-Golkar, S. (1997) Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem. Biol. Interact., 105, 181-198.